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Abstract
Background: Despite the passing of more than a year since the first outbreak of Severe Acute
Respiratory Syndrome (SARS), efficient counter-measures are still few and many believe that
reappearance of SARS, or a similar disease caused by a coronavirus, is not unlikely. For other virus
families like the picornaviruses it is known that pathology is related to proteolytic cleavage of host
proteins by viral proteinases. Furthermore, several studies indicate that virus proliferation can be
arrested using specific proteinase inhibitors supporting the belief that proteinases are indeed
important during infection. Prompted by this, we set out to analyse and predict cleavage by the
coronavirus main proteinase using computational methods.
Results: We retrieved sequence data on seven fully sequenced coronaviruses and identified the
main 3CL proteinase cleavage sites in polyproteins using alignments. A neural network was trained
to recognise the cleavage sites in the genomes obtaining a sensitivity of 87.0% and a specificity of
99.0%. Several proteins known to be cleaved by other viruses were submitted to prediction as well
as proteins suspected relevant in coronavirus pathology. Cleavage sites were predicted in proteins
such as the cystic fibrosis transmembrane conductance regulator (CFTR), transcription factors
CREB-RP and OCT-1, and components of the ubiquitin pathway.
Conclusions: Our prediction method NetCorona predicts coronavirus cleavage sites with high
specificity and several potential cleavage candidates were identified which might be important to
elucidate coronavirus pathology. Furthermore, the method might assist in design of proteinase
inhibitors for treatment of SARS and possible future diseases caused by coronaviruses. It is made
available for public use at our website: http://www.cbs.dtu.dk/services/NetCorona/.
Background
In the spring of 2003, the Severe Acute Respiratory Syn-
drome (SARS) caused numerous fatalities particularly in
Southeast Asia and gravely affected the global economy.
The causative agent was shown to be a human coronavirus
[1], a virus type which normally causes mild cold symp-
toms in humans. The abrupt appearance raises concern of
another break-out of an epidemic of SARS virus or similar
strains in the future.
Coronaviruses are found in different species ranging from
chicken to cattle and humans. Currently, seven coronavi-
rus genomes, including SARS coronavirus (CoV), have
been fully sequenced and cluster into four main groups, of
which SARS-CoV occupies its own [2,3]. Polyproteins
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encoded by the coronavirus RNA are processed by viral
proteinases yielding mature proteins. The main protein-
ase 3CLpro performs at least eleven proteolytic cleavages
within a single viral polyprotein [4,5]. Viral polyprotein
processing is a common theme in viral molecular biology,
e.g. as seen in picornaviruses and retroviruses like HIV.
Therefore, essential viral proteinases have been suggested
as potential targets for specific therapeutic approaches,
e.g. by development of specific proteinase inhibitors [6-
8].
In the case of picornaviruses, virus-encoded proteinases
are able to cleave specific cellular targets and thereby
severely inhibit the cellular translational machinery (the
"host cell shut-off" response) while still allowing for high
translational activity of viral mRNA [9]. Earlier, we devel-
oped a computational approach for predicting potential
cleavage sites of picornavirus proteinases 2A and 3C [10].
Badorff et al. successfully used this cleavage predictor to
identify the cellular target dystrophin, which they experi-
mentally showed to be cleaved both in vitro and in vivo
[11]. However, preliminary studies revealed that this
model is not compatible with coronavirus cleavage sites.
The general approach is still valid though, and we decided
to apply this method to the problem of predicting the
3CLpro proteinase cleavage sites and identifying potential
host cell target proteins. We propose that a deeper under-
standing of coronavirus proteinase function and substrate
specificity may benefit further research by: i) increasing
the understanding of substrate specificity determinants
which may direct studies focusing on the development of
specific proteinase inhibitors and ii) providing a method
for screening cellular target proteins for potential corona-
virus proteinase cleavage sites.
In this paper, we describe the development of a computa-
tional prediction method using artificial neural networks
for predicting coronavirus 3CLpro proteinase cleavage sites.
The method is based on known cleavage sites in seven
members of the coronavirus family as the cleavage sites
are believed to be sufficiently conserved among family
members. This notion is supported by the fact that the
SARS 3CLpro proteinase has recently been shown capable
of catalysing the cleavage of peptide fragments from other
coronaviruses at the expected cleavage sites [12].
We discuss potential targets of 3CLpro proteinase, e.g. the
cystic fibrosis transmembrane conductance regulator
(CFTR) and translational and transcriptional factors,
which may be involved in the molecular pathology of
coronaviruses in general and SARS virus in particular.
Results
Analysis of the proteinase cleavage site
The 77 annotated coronavirus polyprotein main protein-
ase cleavage sites were aligned without gaps by constrain-
ing the P1 position. Every site had a glutamine (Q) in
position P1 (the position just before the cleavage site; the
positions are named as suggested by Berger and Schechter
[13] with P1, P2, ... etc., N-terminal to the cleavage site
and P1', P2', ... etc., C-terminal to the cleavage site). From
the sequence logo (Figure 1) a very strong consensus is
evident around the cleavage site. As discussed by others
[14,15], the coronavirus 3C-like proteinase shares many
traits with its picornavirus 3C proteinase counterpart,
hence the name. This is reflected in the cleavage site logo
although differences between the two are also apparent.
Positions P1', P1, and P4 have similar amino acid distri-
bution in the 3C and 3CL proteinase cleavage sites. On the
other hand, the coronavirus proteinase has a strong pref-
erence for leucine at position P2 while this position is rel-
atively non-conserved among picornavirus proteinase
cleavage sites [10]. A recently published study of the crys-
tal structure of 3CLpro from the 229E strain of human coro-
naviruses indicates that residues at positions P5 to P3
form an anti-parallel β sheet with part of the proteinase,
signifying their importance in cleavage site recognition
[7].
It is clear from the above that a simple, position specific
consensus sequence is difficult to define. With the present
data set from seven different coronaviruses it is possible to
classify correctly 60 (78%) of the 77 cleavage sites by
matching an 'LQ' consensus pattern. However, an addi-
tional 196 sites in the viral polyproteins are incorrectly
classified as cleavage sites, being random occurrences of
this pair of amino acids. Classification is improved by
using the consensus pattern 'LQ [S/A]', meaning Leu-Gln-
(Ser OR Ala), but it is still far from being a useful classifier.
The false positive rate is now down to 36 wrong sites, but
at the same time only 48 (62%) of the correct cleavage
sites are detected. As the pattern becomes more sophisti-
cated, specificity increases (reducing the number of false
positives) but at the same time sensitivity drops dramati-
cally (i.e. fewer of the true sites are detected).
Neural network training and performance
To overcome the limitations of simple consensus patterns,
we trained an artificial neural network to identify the
cleavage sites. The best model was obtained using a three-
layered neural network with two hidden neurons and a
sequence window encompassing nine amino acids cen-
tered on the P1 position, thus encompassing P5-P4'. The
network evaluates and assigns a score between 0 and 1 to
every glutamine to which it is presented, where a score
above 0.5 is considered a positive answer (i.e. a cleavage
site is predicted). This model was able to classify correctly
BMC Bioinformatics 2004, 5 http://www.biomedcentral.com/1471-2105/5/72
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67 of 77 known cleavage sites (87.0%) and 1,358 of 1,372
(99.0%) sites assumed not to be cleaved by the proteinase
when testing on independent sites not included when
training. The neural network method could thus identify
many more of the positive sites with fewer false positives
than simple consensus-type methods thereby increasing
the classification performance. The Matthews correlation
coefficient reached 0.84 for the artificial neural network
compared to 0.37, 0.53 and 0.51 for increasingly complex
consensus patterns ('LQ', 'LQ [S/A]', ' [T/S/A]X [L/F]Q [S/
A/G]' respectively) (Figure 2).
To evaluate the predictive power of the neural network,
we performed a basic bayesian analysis of the data set test
results. The scoring range from 0 to 1 was divided into ten
bins and the posterior probability of a positive prediction
(a prediction indicating a cleavage) being true was calcu-
lated and plotted (Figure 3). The posterior probability in
the range 0.5 to 0.8 cannot be determined accurately since
relatively few examples score in this interval – only 3% of
the test set (both positive and negative examples) scores
between 0.4 and 0.8. However, results indicate that pre-
diction scores can be classified into three categories, those
that fall below 0.5 are most likely not cleaved, those that
fall between 0.5 and 0.8 are possibly cleaved and those
above 0.8 are most likely cleaved if available to the
proteinase.
Analysis of selected human proteins
As mentioned above, there are several experimentally ver-
ified examples of host cell protein cleavage by virus pro-
teinases. Thus, both these and other non-coronavirus
proteins from Swiss-Prot [16] 41.0 were examined for
potential cleavage sites. In total three groups of proteins
were examined: i) proteins known to be cleaved by other
viruses, ii) proteins which could be targets when consider-
ing the pathology of coronaviruses iii) proteins related to
the expected immune response to a viral infection.
Eukaryotic translation initiation factor 4 gamma
(IF4G_HUMAN) has a potential cleavage site after
Gln838 (0.822), but also at two other positions although
with lower cleavage scores. Cleavage of this protein may
lead to host cell shut-off in a similar way to what has been
described for picornavirus 2A proteinase [17].
Two subunits of the RNA polymerase III are predicted tar-
gets of the coronavirus proteinase 3CLpro. RNA polymerase
(RPC1_HUMAN) has a predicted cleavage site after
Glnl95 with a score (0.765) well above the 0.5 cut-off. The
protein is the second largest subunit of the RNA
polymerase III complex and if this protein is indeed a cel-
lular proteinase target it might cause disruption of the
RNA polymerase III complex upon infection with a coro-
navirus. A similar disruption would be expected in case of
a cleavage of the largest subunit of the complex
(RPA1_HUMAN) which also has a predicted cleavage site
(at position 329, score 0.704). It agrees with findings that
poliovirus disrupts RNA polymerase III function,
although this occurs through cleavage of transcription fac-
tor IIIC and not the polymerase subunits themselves [18-
20]. Several well-known transcription factors contain
potential cleavage sites. The highest scoring is CREB-RP
(AT6B_HUMAN) with a predicted cleavage site at Gln358
(0.916) close to the DNA binding leucine zipper motif.
This is in agreement with findings from picornavirus 3Cpro
proteinase although at a different position in the sequence
[21]. OCT-1 (PO21_HUMAN) is also predicted to be
cleaved by the 3CLpro proteinase with high confidence
(0.874) following Gln62 again corresponding to experi-
mental evidence from picornavirus [22]. Several subunits
of the transcription initiation factor TFIID, which is a ver-
ified target in poliovirus infections [23], have predicted
cleavage sites; the 250 kDa subunit (T2D1_HUMAN), the
135 kDa subunit (T2D3_HUMAN), and the 105 kDa sub-
unit (T2DT_HUMAN).
The tumor-suppressor protein P53 is known to be cleaved
by picornavirus 3Cpro proteinase [24] but this protein is
not predicted to contain any coronavirus 3Cpro proteinase
cleavage sites. However, P53-binding protein 1
(P531_HUMAN) and P53-binding protein 2
(P532_HUMAN), which stimulate p53-mediated tran-
scriptional activation [25], have several potential cleavage
sites.
Another known target for viral infections is the microtu-
bule-associated protein 4 (MAP-4) which is cleavable in
HeLa cells by the poliovirus 3Cpro proteinase [26,27].
MAP-4 (MAP4_HUMAN) might also be cleavable by
Logo plot of a multiple alignment of 77 coronavirus cleavage sitesFi ure 1
Logo plot of a multiple alignment of 77 coronavirus 
cleavage sites. The height of the letters reflects the Shan-
non information at individual positions (see Methods section 
for detailed information).
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3CLpro albeit with a low score (after Gln 1005 with a score
of 0.519) and furthermore microtubule-associated pro-
tein RP/EB member 1 and 3 (MAE1_HUMAN and
MAE3_HUMAN) have sites which obtain scores above
0.5. The position of the possible cleavage site in MAP-4 is
different from that observed with poliovirus 3Cpro reflect-
ing the different specificity of this proteinase.
Lung related proteins were examined as early symptoms
of SARS could indicate a relation. The cystic fibrosis trans-
membrane conductance regulator (CFTR_HUMAN) is an
ATP-dependent chloride channel. It has a predicted cleav-
age site with a high score (0.842) following Gln762 in the
human sequence. This part of the membrane protein is
cytoplasmic and contains several phosphorylation sites
(residues 660 – 813) indicating an accessible region.
The epithelial sodium channels play an important role in
lung liquid homeostasis [28] and the amiloride-sensitive
sodium channel δ-subunit (SCAD_HUMAN) has a pre-
dicted cleavage site in the cytoplasmic C-terminus (after
residue 22) scoring 0.828. A number of proteins involved
in the ubiquitin pathway which targets proteins to the
proteasome, a necessary step to generate an immune
response, have predicted cleavage sites (Swiss-Prot entries
UBP1_HUMAN, SOC6_HUMAN, UBPD_HUMAN,
UBP4_HUMAN, UBP5_HUMAN, UBPQ_HUMAN,
FAFY_HUMAN, FAFX_HUMAN). Cleavage of one or
Method performance comparisonFigure 2
Method performance comparison. Using consensus patterns or neural network (NN) to identify cleavage sites. Green 
bars are percentage of true positives, red bars are percentage of true negatives and blue bars are Matthews correlation coeffi-
cients multiplied with 100.
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more of these proteins may lead to reduced presentation
of viral peptides to cytotoxic T lymphocytes thereby
inhibiting the cellular immune response. IRAK-1
(IRA1_HUMAN) which is involved in IL-1 induced activa-
tion of cells has a predicted cleavage site after Gln457
scoring 0.859.
Interferon-induced protein 6–16 precursor
(INI2_HUMAN) is a membrane protein and was pre-
dicted to possess a cleavage site following Gln97 (0.890)
which is located in the cytoplasmic part of the mature pro-
tein. Protein 6–16 has been shown to enhance interferon-
α antiviral efficacy [29]. Interferon-α, -β, and -γ are known
to be involved in antiviral defence and have been
employed for treatment of SARS [30], but the interferons
themselves do not seem to possess cleavage sites.
We have listed the human proteins analysed in this work
in a table (Table 1).
Discussion
We have developed a neural network capable of identify-
ing the cleavage site of the coronavirus proteinase 3CLpro
and use this model to predict potential cleavage sites in
host cell proteins. The predictor is highly specific which
means that few false positives are expected, in fact on
independent test sets we observed a false positive rate
around 1%. The optimal network window size of nine res-
idues agrees well with available structural information
about the proteinase from human coronavirus 229E
which indicates that the active site makes contact with at
least four residues N-terminal to the glutamine [7].
The ten sites known to be cleaved but failed to be recog-
nised by the neural network are not dramatically different
from the remainder of the sites (Table 2). We therefore do
not suspect these to be sites of a different hitherto
unknown proteinase, but it would be interesting to see if
the lower prediction score reflects a lower cleavage effi-
ciency in vivo. Of the fourteen negative examples wrongly
predicted as cleavable (Table 3), the highest scoring were
examined more closely. The selected examples all show
Reliability analysis of data set test resultsFigure 3
Reliability analysis of data set test results. Scoring range (0 – 1) was divided into ten bins. The fraction of negative exam-
ples in each bin is illustrated with red bars, the fraction of positive examples is illustrated with green bars, blue bars are poste-
rior probabilities of a true cleavage prediction (see Methods section for detailed information).
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some resemblance to real cleavage sites but also some
resemblance to negative examples which are not predicted
as cleavable. They may represent sites in-between which
are cleavable to a certain extent but are shielded from
cleavage due to conformational issues.
Predicted sites even with high scores which are inaccessi-
ble to the proteinase (like extracellular domains,
transmembrane domains, or buried domains in globular
proteins) should be disregarded, as accessibility informa-
tion is not available to the neural network. Cleavage sites
probably exist that are not cleaved because they are not
exposed to the solvent sufficiently for the proteinase to
work.
Others have attempted recognising the cleavage sites of
the 3CL proteinase as a component of a coronavirus gene
prediction server using different methods [31]. As the goal
Table 1: Selected potential cleavage sites in human proteins from the Swiss-Prot database examined in this work. Columns represent 
Swiss-Prot identifier, predicted cleavage site position of P1 in the target protein, cleavage site score, and cellular localisation of target 
protein (Cyt – cytoplasmic, Nuc – nuclear, Mem – membrane associated). The last column lists the cleavage site in the sequence – 
cleavage is predicted between the central glutamine residue (Q) and the following amino acid residue. Sorted by prediction score.
Swiss-Prot ID Loc Position Score Sequence
AT6B_HUMAN Nuc 358 0.916 EARLQAVLAD
INI2_HUMAN Mem 97 0.890 VATLQSLGAG
PO21_HUMAN Nuc 62 0.874 GTSLQAAAQS
IRA1_HUMAN Cyt 457 0.859 QSTLQAGLAA
CFTR_HUMAN Mem 762 0.842 GPTLQARRRQ
SCAD_HUMAN Mem 22 0.828 GSHLQAAAQT
P532_HUMAN Nuc 308 0.782 ASVPQSTGNA
RPC1_HUMAN Cyt 195 0.765 SNFLQSFETA
P531_HUMAN Nuc 196 0.738 KEQLQSVTTN
T2D1_HUMAN Nuc 741 0.730 GQLLQAFENN
P532_HUMAN Nuc 197 0.725 KAALQQKENL
RPA1_HUMAN Cyt 329 0.704 TVNLQAVMKD
CFTR_HUMAN Mem 958 0.693 HSVLQAPMST
MAE1_HUMAN Cyt 64 0.661 KVKFQAKLEH
MAE3_HUMAN Cyt 64 0.661 KVKFQAKLEH
P531_HUMAN Nuc 410 0.660 QKKLQSGEPV
CFTR_HUMAN Mem 890 0.654 NTPLQDKGNS
P532_HUMAN Nuc 722 0.624 SPNLQNNPEE
T2DT_HUMAN Nuc 133 0.619 PSSVQSVAVP
T2D3_HUMAN Nuc 610 0.570 SSGKQSTETA
MAP4_HUMAN Cyt 1005 0.519 YSHIQSKCGS
Table 2: Known main proteinase cleavage sites in coronavirus polyproteins used in this study, which were missed by the neural network 
during cross-validation. Position refers to position in the viral polyprotein. The last column lists the cleavage site in the sequence – 
cleavage occurs between the central glutamine residue (Q) and the following amino acid residue.
Accession Position Virus Sequence
NC_001451 3928 AIBV KSSVQSVAG
NC_001846 3923 MHV VSQIQSRLT
NC_001846 5984 MHV NPRLQCTTN
NC_002306 5527 TGV KIGLQAKPE
NC_003045 5900 BCoV ETRVQCSTN
NC_003436 3299 PEDV GVNLQGGYV
NC_003436 6141 PEDV SNNLQGLEN
NC_004718 3546 SARS GVTFQGKFK
NC_004718 4369 SARS EPLMQSADA
NC_004718 5902 SARS VATLQAENV
BMC Bioinformatics 2004, 5 http://www.biomedcentral.com/1471-2105/5/72
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was different, that predictor is not publicly available and
no performance values have been published.
Conclusions
Our method can be employed by researchers suspecting a
possible viral proteinase cleavage but may also prove use-
ful for researchers working with coronavirus function.
Finally, the method might facilitate proteinase blocking
based drug discovery by providing hints about proteinase
affinity to various non-cleavable peptide ligands, which is
a possible strategy for drug development [7,32].
Methods
Data Set Preparation
Seven full-length coronavirus genomes were retrieved
from the GenBank database [33] with the following acces-
sion numbers: NC_001451 (Avian infectious bronchitis
virus, AIBV), NC_001846 (Murine hepatitis virus, MHV),
NC_002645 (Human coronavirus 229E, HCoV-229E),
NC_003436 (Porcine epidemic diarrhea virus, PEDV),
NC_003045 (Bovine coronavirus, BCoV), NC_002306
(Transmissible gastroenteritis virus, TGV), and the TOR2
strain of SARS NC_004718. Deduced polyprotein
sequences were aligned and cleavage sites identified from
the annotation in NC_004718. Each sequence contained
eleven 3CLpro proteinase cleavage sites, thus a total of 77
of these sites were identified. For training a neural net-
work classifier, a number of negative examples (presumed
non-cleavage sites) are required. For this purpose, all
other glutamines in the viral polyproteins were treated as
non-cleavable sites.
Three test sets were created for three-fold cross-validation
and the training set for one was created by combining the
two other test sets. Every test set thus contained 483 exam-
ples of which 25 or 26 were positive examples. All testing
and results reported are combined values of the three test
sets, which are run individually with three separate neural
networks to avoid testing on sequences included in train-
ing sets.
Sequence logos
Amino acid conservation in multiple sequence align-
ments may be visualised using sequence logos. The height
of the amino acid one-letter abbreviations reflect the
Shannon information content [34] in units of bits at that
specific position in the multiple sequence alignment [35].
The basic idea behind the visualisation technique is that
the height of each letter in a given position reflects its
probability pk(i). The total height of the column reflects
the total information content (D(i)) at that specific posi-
tion in the alignment given by (for proteins):
Very conserved positions will then get tall columns with
the height of individual residue symbols reflecting the
amino acid distribution.
Training the neural networks
The artificial neural networks used in this work were of the
standard feed-forward type. Sparse encoding was used for
translating the amino acids to data input for the networks
as has been described previously [36,10,37].
Training was done with three-fold cross-validation and
Matthews correlation coefficients [38] were calculated by
Table 3: Negative examples predicted to be cleaved by the neural network during cross-validation. Position refers to position in the viral 
polyprotein. The last column lists the cleavage site in the sequence – cleavage is predicted between the central glutamine residue (Q) 
and the following amino acid residue.
Accession Position Virus Sequence
NC_001846 3607 MHV HSGFQGKQI
NC_001846 6613 MHV YTDLQCIES
NC_002306 1457 TGV ETSLQCLLK
NC_002306 5747 TGV YSSSQSVYA
NC_002306 698 TGV ETNIQAIKN
NC_002306 85 TGV SVMLQGFIV
NC_002645 1169 HCoV-229E IRQLQGTII
NC_002645 2659 HCoV-229E YSSIQANAY
NC_002645 322 HCoV-229E VIALQSVDC
NC_003045 1364 BCoV DARTQGKQS
NC_003045 1498 BCoV RTFVQSNVD
NC_003045 2713 BCoV SSDFQHKLK
NC_003045 311 BCoV VMRLQSAST
NC_003436 1751 PEDV SAGLQAMWE
D i p i p ik k
k
( ) log ( )log ( )= +
=
∑2 2
1
20
20
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summing up true positives, false positives, true negatives,
and false negatives in all combinations of training and test
sets. Using an architecture with two hidden neurons and
a symmetric window of nine amino acids centered on the
glutamine in the P1 position it was possible to obtain a
correlation coefficient of 0.84 on cross-validated test sets.
Care was taken to ensure that all cleavage sites were
equally distributed in every cross-validated set.
Bayesian statistics
The validity of the statistics depends on the expected frac-
tion of cleavage sites in a given data set, which we only
know in the data set at hand. Statistics was thus done on
the data set test results in order to create a histogram of
prediction probabilities. Statistics was done using Bayes'
Theorem:
The prediction outcome (0–1) was divided into 10 bins
(Xl) with increments of 0.1. The posterior probability
P(Cpos|Xl) gives the probability of a positive prediction
(that is, a cleavage) being true given the bin. This can be
calculated from the prior probability P(Cpos), which is the
fraction of positive examples in the data set, and the class-
conditional probability P(Xl|Cpos) for positive examples,
which is the fraction of positive examples in the bin Xl.
P(Xl) is the fraction of prediction outcomes in bin Xl.
Searching for potential cleavage sites
An averaged sum of the score of all three networks arising
from the three-fold cross-validation was used for predic-
tion. Each network outputs a score in the range [0.000–
1.000], where scores below 0.5 indicate non-cleavage and
scores above 0.5 indicate potential cleavage. This method
is also employed by the prediction web server mentioned
below. The Swiss-Prot database [16] release 41.0 (Febru-
ary 2003) was downloaded and proteins from this
database were used as targets for the neural network
predictions.
Availability
Our neural network based prediction method, NetCo-
rona, for prediction of potential cleavage sites of the SARS-
3CLpro proteinase is publicly available by following the
link 'CBS prediction servers' from http://www.cbs.dtu.dk
or at this specific URL: http://www.cbs.dtu.dk/services/
NetCorona/
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